Recurrent or Refractory Medulloblastoma
1 clinical trials · Condition
◉ Watch Recurrent or Refractory Medulloblastoma
| Record | Firm | Date |
|---|---|---|
| A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors (NCT01106508) | Novartis Pharmaceuticals | 2010-10-01 |
Track Recurrent or Refractory Medulloblastoma automatically
Every clearance here is in the API, with alerts when new ones post.